| Status: Superseded | |
AWMSG ADVICE SUPERSEDED BY NICE GUIDANCE ISSUED APRIL 2021. Refer to TA804: Teduglutide for treating short bowel syndrome |
|
Medicine details |
|
| Medicine name | teduglutide (Revestive) |
| Formulation | powder and solvent for solution for injection |
| Reference number | 905 |
| Indication | Treatment of patients aged 1 year and above with short bowel syndrome |
| Company | Takeda UK Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Superseded |
| Date of issue | 12/07/2019 |
| NICE guidance | |
| Commercial arrangement | PAS |